Investor Relations

Q4 2023 Earnings Conference Call

March 28, 2024 - 4:30 PM ET

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2022

Stock Snapshot

Company Overview

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

IR Contacts

Company

Achieve Life Sciences, Inc.
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
T: 425-686-1500

Investor Relations

Rich Cockrell
T: 404-736-3838
achv@cg.capital